EIGR logo

Eiger BioPharmaceuticals (EIGR)

Profile

Full Name

Eiger BioPharmaceuticals, Inc.

Ticker Symbol

EIGR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 30, 2014

Indexes

Not included

Website

http://www.eigerbio.com

Employees

56

Key Details

Price

$1.73

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$15.77M(+16.98% YoY)

Annual EPS

-$50.78(+27.04% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.73
EIGR price is $1.73

30-Day Relative Volume

4.80
EIGR 30-day relative volume is 4.80

Price Performance

Price Most recent change

-
EIGR price change on Apr 1, 2025 is unknown

Price YTD change

-
EIGR price ytd change is unknown

Price 1-year change

-18.25%
EIGR price is down -18.25% year-on-year

Price 3-year change

-99.18%
EIGR price is down -99.18% over the past 3 years

Price Range

Price All-time high

$12712.50
EIGR price is currently -99.99% below its historical high of $12712.50

Price 3-year low

$1.10
EIGR price is currently +56.82% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.55M
EIGR market capitalization is $2.55 million

Market cap 3-year change

-99.11%
EIGR market capitalization is down -99.11% over the past 3 years

Market cap All-time high

$650.15M
EIGR market capitalization is currently -99.61% below its historical high of $650.15 million

Market cap sector rank

7.98%
EIGR market capitalization is higher than 7.98% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
EIGR {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

+9.59%
EIGR shares outstanding is up +9.59% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

2.44
EIGR beta is 2.44

200-day SMA

$6.56
EIGR price is currently -73.72% below its 200-day simple moving average

50-day SMA

$9.29
EIGR price is currently -81.43% below its 50-day simple moving average

RSI

34.33
EIGR 14-day relative strength index is 34.33

Volume

4.80
EIGR 30-day relative volume is 4.80

ATR

$1.04
EIGR average true range is $1.04

10-day Historical Volatility

400.14%
EIGR 10-day historical volatility is 400.14%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$15.77M
EIGR annual revenue is $15.77 million

Revenue Analysts estimate

$25.22M
EIGR annual revenue is currently -37.46% lower than the consensus analysts' forecast

Revenue 1-year change

+16.98%
EIGR annual revenue is up +16.98% year-on-year

Revenue Sector rank

32.47%
EIGR annual revenue is higher than 32.47% of companies in Healthcare sector

EPS

EPS

-$50.78
EIGR annual earnings per share is -$50.78

EPS Analysts estimate

-$15.60
EIGR annual earnings per share is currently +225.51% higher than the consensus analysts' forecast

EPS 1-year change

+27.04%
EIGR annual earnings per share is up +27.04% year-on-year

EPS Sector rank

3.97%
EIGR annual earnings per share is higher than 3.97% of companies in Healthcare sector

Profit

Gross profit

$15.75M
EIGR annual gross profit is $15.75 million

Gross margin

99.85%
EIGR annual gross profit margin is 99.85%

Operating profit

-$71.79M
EIGR annual operating income is -$71.79 million

Operating margin

-455.12%
EIGR annual operating profit margin is -455.12%

Net income

-$74.96M
EIGR annual net profit is -$74.96 million

Net margin

-
EIGR annual net profit margin value is unknown

Expenses

Total expenses

$87.56M
EIGR annual total expenses is $87.56 million

Operating expenses

$87.53M
EIGR annual total operating expenses is $87.53 million

Cost of goods sold

$24.00K
EIGR annual cost of goods sold is $24.00 thousand

Selling, general & administrative expenses

$25.20M
EIGR annual SGA is $25.20 million

Depreciation and amortization

$750.00K
EIGR annual depreciation & amortization is $750.00 thousand

Interest expense

$5.47M
EIGR annual interest expense is $5.47 million

Income tax

$6000.00
EIGR annual income tax is $6000.00

EBIT & EBITDA

EBIT

-$69.49M
EIGR annual earnings before interest & taxes is -$69.49 million

EBITDA

-$68.74M
EIGR annual EBITDA is -$68.74 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$38.83M
EIGR annual total assets is $38.83 million

Non current assets

$987.00K
EIGR annual long term assets is $987.00 thousand

Current assets

$37.84M
EIGR annual total current assets is $37.84 million

Cash and cash equivalents

$25.44M
EIGR annual cash & cash equivalents is $25.44 million

Accounts receivable

$1.68M
EIGR annual accounts receivable is $1.68 million

Inventory

$1.56M
EIGR annual inventory is $1.56 million

Liabilities

Total liabilities

$53.28M
EIGR annual total liabilities is $53.28 million

Long term liabilities

$0.00
EIGR annual total long term liabilities is $0.00

Current liabilities

$53.28M
EIGR annual total current liabilities is $53.28 million

Accounts payable

$2.12M
EIGR annual accounts payable is $2.12 million

Debt

Total debt

$41.20M
EIGR annual total debt is $41.20 million

Total debt 1-year change

+2.5%
EIGR annual total debt is up +2.5% year-on-year

Long term debt

$0.00
EIGR annual long term debt is $0.00

Short term debt

$41.12M
EIGR annual short term debt is $41.12 million

Equity & Capital

Shareholders equity

-$14.46M
EIGR annual stockholders equity is -$14.46 million

Book value

-$14.46M
EIGR annual book value is -$14.46 million

Retained earnings

-$512.16M
EIGR annual retained earnings is -$512.16 million

Working capital

-$15.45M
EIGR annual working capital is -$15.45 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$74.55M
EIGR annual cash flow from operations is -$74.55 million

Cash from operations 1-year change

+10.19%
EIGR annual cash flow from operations is up +10.19% year-on-year

Cash from investing

$74.23M
EIGR annual cash flow from investing activities is $74.23 million

Cash from investing 1-year change

+670.64%
EIGR annual cash flow from investing activities is up +670.64% year-on-year

Cash from financing

$41.00K
EIGR annual cash flow from financing activities is $41.00 thousand

Cash from financing 1-year change

-99.95%
EIGR annual cash flow from financing activities is down -99.95% year-on-year

CAPEX

CAPEX

$234.00K
EIGR annual capital expenditures is $234.00 thousand

CAPEX 1-year change

-31.18%
EIGR annual capital expenditures is down -31.18% year-on-year

Free Cash Flow

Free cash flow

-$74.78M
EIGR annual free cash flow is -$74.78 million

Free cash flow 1-year change

+10.28%
EIGR annual free cash flow is up +10.28% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

99.85%
EIGR annual gross profit margin is 99.85%

Operating margin

-455.12%
EIGR annual operating profit margin is -455.12%

Net margin

-
EIGR annual net profit margin value is unknown

ROA & ROE

ROA

-193.07%
EIGR annual return on assets is -193.07%

ROE

518.49%
EIGR annual return on equity is 518.49%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
EIGR price to earnings ratio value is unknown

PE ratio Sector rank

-
EIGR price to earnings ratio is unknown

PB Ratio

PB ratio

-0.18
EIGR price to book ratio is -0.18

PB ratio Sector rank

11.94%
EIGR price to book ratio is higher than 11.94% of companies in Healthcare sector

PS Ratio

PS ratio

0.16
EIGR price to sales ratio is 0.16

PS ratio Sector rank

6.41%
EIGR price to sales ratio is higher than 6.41% of companies in Healthcare sector

Enterprise value

Enterprise value

$18.32M
EIGR enterprise value is $18.32 million

Enterprise value Sector rank

30.88%
EIGR enterprise value is higher than 30.88% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.27
EIGR EV/EBITDA is -0.27

EV/EBITDA Sector rank

56.61%
EIGR EV/EBITDA is higher than 56.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.71
EIGR annual current ratio is 0.71

Quick ratio

0.68
EIGR annual quick ratio is 0.68

Leverage

Debt to equity

-2.85
EIGR annual debt to equity ratio is -2.85

Interest coverage ratio

-12.71
EIGR annual interest coverage ratio is -12.71

Risk & Stability

Piotroski F-Score

4
EIGR piotroski f-score is 4

Altman Z-Score

-24.42
EIGR altman z-score is -24.42

Analyst ratings

Recent major analysts updates

Aug 29, 23 Citigroup
Buy
Jun 30, 23 Baird
Outperform
Sep 7, 22 BTIG
Buy
Aug 9, 21 Citigroup
Buy
Apr 3, 20 Wedbush
Outperform
Jan 22, 20 Ladenburg Thalmann
Buy
Jun 26, 19 Citigroup
Buy
Jan 29, 19 Baird
Outperform
May 17, 18 BTIG Research
Buy
May 17, 18 BTIG
Buy

Institutional Ownership

Similar stocks

OMGA logo
Omega Therapeutics (OMGA)
ENSC logo
Ensysce Biosciences (ENSC)
ADTX logo
Aditxt (ADTX)
QLGN logo
Qualigen Therapeutics (QLGN)
CNSP logo
CNS Pharmaceuticals (CNSP)
AIM logo
AIM ImmunoTech (AIM)
REVB logo
Revelation Biosciences (REVB)
Catheter Precision (VTAK)
ENVB logo
Enveric Biosciences (ENVB)
  • What is the ticker symbol for Eiger BioPharmaceuticals?
  • Does Eiger BioPharmaceuticals pay dividends?
  • What sector is Eiger BioPharmaceuticals in?
  • What industry is Eiger BioPharmaceuticals in?
  • What country is Eiger BioPharmaceuticals based in?
  • When did Eiger BioPharmaceuticals go public?
  • Is Eiger BioPharmaceuticals in the S&P 500?
  • Is Eiger BioPharmaceuticals in the NASDAQ 100?
  • Is Eiger BioPharmaceuticals in the Dow Jones?
  • When was Eiger BioPharmaceuticals's last earnings report?
  • When does Eiger BioPharmaceuticals report earnings?
  • Should I buy Eiger BioPharmaceuticals stock now?

What is the ticker symbol for Eiger BioPharmaceuticals?

The ticker symbol for Eiger BioPharmaceuticals is NASDAQ:EIGR

Does Eiger BioPharmaceuticals pay dividends?

No, Eiger BioPharmaceuticals does not pay dividends

What sector is Eiger BioPharmaceuticals in?

Eiger BioPharmaceuticals is in the Healthcare sector

What industry is Eiger BioPharmaceuticals in?

Eiger BioPharmaceuticals is in the Biotechnology industry

What country is Eiger BioPharmaceuticals based in?

Eiger BioPharmaceuticals is headquartered in United States

When did Eiger BioPharmaceuticals go public?

Eiger BioPharmaceuticals's initial public offering (IPO) was on January 30, 2014

Is Eiger BioPharmaceuticals in the S&P 500?

No, Eiger BioPharmaceuticals is not included in the S&P 500 index

Is Eiger BioPharmaceuticals in the NASDAQ 100?

No, Eiger BioPharmaceuticals is not included in the NASDAQ 100 index

Is Eiger BioPharmaceuticals in the Dow Jones?

No, Eiger BioPharmaceuticals is not included in the Dow Jones index

When was Eiger BioPharmaceuticals's last earnings report?

Eiger BioPharmaceuticals's most recent earnings report was on May 10, 2024

When does Eiger BioPharmaceuticals report earnings?

The date for Eiger BioPharmaceuticals's next earnings report has not been announced yet

Should I buy Eiger BioPharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page